Cart
sales@molnova.com
Sultiame
CAS No. 61-56-3
Sultiame( —— )
Catalog No. M26833 CAS No. 61-56-3
Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSultiame
-
NoteResearch use only, not for human use.
-
Brief DescriptionSultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.
-
DescriptionSultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.(In Vitro):Sultiame promotes a modest intracellular acidosis in central neurons via acting as a carbonic anhydrase inhibitor, thereby reducing the frequency of action potentials and epileptiform bursts.
-
In VitroSultiame (Sulthiame) is a sulphonamide, and it may exerts antiepileptic activity by producing a modest intracellular acidosis in central neurons via acting as a carbonic anhydrase inhibitor, thereby reducing the frequency of action potentials and epileptiform bursts.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorM1 mAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61-56-3
-
Formula Weight290.35
-
Molecular FormulaC10H14N2O4S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (172.20 mM)
-
SMILESNS(=O)(=O)c1ccc(cc1)N1CCCCS1(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lv X, et al. M(1) muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons. Neuropharmacology. 2017 May 15;118:209-222.
molnova catalog
related products
-
Bradykinin
Bradykinin is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothelium-Derived Hyperpolarizing Factor. Bradykinin is a physiologically and pharmacologically active peptide of the kinin group of proteins, consisting of nine amino acids.
-
3-O-Feruloylquinic a...
3-O-Feruloylquinic acid is a protease inhibitor, it exerts moderate inhibitory effect against AIV (H5N1) in vitro.
-
Allisartan Isoproxil
Allisartan Isoproxil, an angiotensin II receptor antagonist, is used to treat mild to moderate essential hypertension.
